Browse EX-10 agreements

EMPLOYMENT AGREEMENT

This Employment Agreement (“Agreement”) is made between Klaviyo, Inc., a Delaware corporation (the “Company”), and Erica Smith (the “Executive”).

WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company beginning on September 1, 2026 or such other date as may be mutually agreed between the parties (the “Effective Date”) on the terms and conditions contained herein.

NOW, THEREFORE,in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:

1.Employment.

…

LEASE AGREEMENT

THIS LEASE AGREEMENT (this “Lease”) is made and entered into by and between IVT PPD Hudson Associates, L.L.C., a Delaware limited liability company (“Landlord”), and GEO Secure Services, LLC, a Florida limited liability company (“Tenant”), to be effective as of August 1, 2026 (the “Commencement Date”).

ARTICLE I- DESCRIPTION OF LEASED PREMISES

Section 1.1.    Landlord, in consideration of the rents reserved and the covenants and agreements herein contained to be kept and performed by Tenant, hereby lets, rents, leases and demises unto Tenant the following described premises (the “Premises”) known as the Hudson Correction Facility and located at 3001 Juniper Street, Hudson, CO 80642 and further described in Exhibit Aattached hereto and incorporated herein for all purposes. The Premises includes all improvements currently existing as of the Commencement Date, which are referred to herein as “Existing Improvements.” Any alterations or additions made by or on behalf of Tenant to the Premises from and after the Commencement Date or fixtures installed by Tenant from and

…

AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT

This AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED FIRST LIEN CREDIT AGREEMENT, dated as of July 8, 2026 (this “Fourth Amendment”), by and among Shift4 Payments, LLC, a Delaware limited liability company (the “Borrower”), the Subsidiary Guarantors party hereto, each Person identified on the signature pages hereto as an “Amendment No. 4 Incremental Term Lender” (collectively, the “Amendment No. 4 Incremental Term Lenders”), the Revolving Lenders party hereto and Goldman Sachs Bank USA (“Goldman”), as administrative agent and collateral agent for the Secured Parties (in such capacities together with its successors and assigns, the “Administrative Agent”). Capitalized terms not otherwise defined in this Fourth Amendment have the meanings specified in the Amended Credit Agreement (as defined below).

RECITALS

…

MATINAS BIOPHARMA HOLDINGS, INC.

July 10, 2026

Holder of Warrants Issued in February 2025 and April 2025

Re:	Inducement Offer to Exercise Warrants Holder of Warrants Issued in February 2025 and April 2025

Dear Holder:

…

FORM OF VOTING AGREEMENT

This Voting Agreement (this “Agreement”) is made as of July 10, 2026 by and among (i) GH Power Inc., a corporation organized under the laws of Ontario (the “GH Power”), (ii) Matinas BioPharma Holdings, Inc., a Delaware corporation (“Matinas”), and (iii) the undersigned stockholder (“Holder”) of Matinas. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the BCA.

…

FORM OF VOTING AGREEMENT

This Voting Agreement (this “Agreement”) is made as of July 10, 2026 by and among (i) GH Power Inc., a corporation organized under the laws of Ontario (the “GH Power”), (ii) Matinas BioPharma Holdings, Inc., a Delaware corporation (“Matinas”), and (iii) the undersigned shareholder (“Holder”) of GH Power. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the BCA.

…

WARRANT SOLICITATION AGENT AGREEMENT

THIS WARRANT SOLICITATION AGENT AGREEMENT (this “Agreement”) is dated as of July 10, 2026, by and between Matinas BioPharma Holdings, Inc. (the “Company”) and ThinkEquity LLC (“ThinkEquity” or the “Solicitation Agent”).

RECITALS

** **

WHEREAS, pursuant to certain prior offerings, the Company issued to the holders of certain existing warrants(the “Holders”), among others, common stock purchase warrants to purchase the number of shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), set forth opposite of such Holder’s name, at an initial exercise price of $0.6446 per share, subject to adjustment as provided therein (the “Existing Warrants”);

** **

WHEREAS, based on certain anti-dilution adjustments that will occur immediately prior to the closing of the transactions contemplated hereunder it is anticipated that the exercise price of the Existing Warrants will be adjusted to $0.35 per share (the “Current Exercise Price”)

…

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of July 10, 2026, between Matinas BioPharma Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement (the “Offering”).

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

…

FOURTH AMENDMENT

TO

EMPLOYMENT AGREEMENT

This Fourth Amendment (“Amendment”), entered into as of the 10th day of July, 2026 (the “Effective Date”), amends the Employment Agreement between MATINAS BIOPHARMA HOLDINGS, INC. (the “Company”) and Jerome D. Jabbour (the “Executive”) dated March 22, 2018, as amended by those certain amendments dated as of March 3, 2023, April 30, 2025 and December 12, 2025 (as amended, the “Agreement”). All capitalized terms not defined herein shall have the meanings set forth in the Agreement.

RECITALS

** **

WHEREAS, the Company and the Executive desire to amend the Agreement as provided in this Amendment, to modify the terms of the Retention Bonus thereunder to apply if a “Change in Control” (as defined therein) occurs on or before December 31, 2026.

NOW THEREFORE, in consideration of the foregoing premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned, intending to be legally bound, hereby agree as follows:

1. Retention Bonus.

…

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of July 10, 2026, between Matinas BioPharma Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement (the “Offering”).

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

…

FOURTH AMENDMENT

TO

EMPLOYMENT AGREEMENT

This Fourth Amendment (“Amendment”), entered into as of the 10th day of July, 2026 (the “Effective Date”), amends the Employment Agreement between MATINAS BIOPHARMA HOLDINGS, INC. (the “Company”) and Jerome D. Jabbour (the “Executive”) dated March 22, 2018, as amended by those certain amendments dated as of March 3, 2023, April 30, 2025 and December 12, 2025 (as amended, the “Agreement”). All capitalized terms not defined herein shall have the meanings set forth in the Agreement.

RECITALS

** **

WHEREAS, the Company and the Executive desire to amend the Agreement as provided in this Amendment, to modify the terms of the Retention Bonus thereunder to apply if a “Change in Control” (as defined therein) occurs on or before December 31, 2026.

NOW THEREFORE, in consideration of the foregoing premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned, intending to be legally bound, hereby agree as follows:

1. Retention Bonus.

…

WARRANT SOLICITATION AGENT AGREEMENT

THIS WARRANT SOLICITATION AGENT AGREEMENT (this “Agreement”) is dated as of July 10, 2026, by and between Matinas BioPharma Holdings, Inc. (the “Company”) and ThinkEquity LLC (“ThinkEquity” or the “Solicitation Agent”).

RECITALS

** **

WHEREAS, pursuant to certain prior offerings, the Company issued to the holders of certain existing warrants(the “Holders”), among others, common stock purchase warrants to purchase the number of shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), set forth opposite of such Holder’s name, at an initial exercise price of $0.6446 per share, subject to adjustment as provided therein (the “Existing Warrants”);

** **

WHEREAS, based on certain anti-dilution adjustments that will occur immediately prior to the closing of the transactions contemplated hereunder it is anticipated that the exercise price of the Existing Warrants will be adjusted to $0.35 per share (the “Current Exercise Price”)

…